Publications by Statistical Genetics and Epidemiology Our research spans areas of statistical genetics, in particular the development of powerful statistical approaches to analyse genetic data, as well as studying infectious diseases. Bhatia, S. et al. (2021) “Estimating the number of undetected COVID-19 cases among travellers from mainland China”, Wellcome Open Research, 5, p. 143. Davies, B. et al. (2021) “Altering the binding properties of PRDM9 partially restores fertility across the species boundary”, Molecular Biology and Evolution, 38(12), pp. 5555–5562. Siejka-Zielinska, P. et al. (2021) “Cell-free DNA TAPS provides multimodal information for early cancer detection”, Science Advances, 7(36). Lushasi, K. et al. (2021) “Reservoir dynamics of rabies in south-east Tanzania and the roles of cross-species transmission and domestic dog vaccination”, Journal of Applied Ecology, 58(11), pp. 2673–2685. Jiang, X., Holmes, C. and McVean, G. (2021) “The impact of age on genetic risk for common diseases”, PLOS Genetics, 17(8). Dorigatti, I. et al. (2021) “Author Correction: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’”, Nature Communications, 12(1), p. 5020. Mishra, S. et al. (2021) “Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling”, Scientific Reports, 11. Redd, R. et al. (2021) “Behavioural responses to SARS-CoV-2 antibody testing in England: REACT-2 study”, Wellcome Open Research, 6, p. 203. Williams, L. et al. (2021) “Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates”, p. 2021.07.30.21260912. Ward, H. et al. (2021) “Increasing SARS-CoV-2 antibody prevalence in England at the start of the second wave: REACT-2 Round 4 cross-sectional study in 160,000 adults”, p. 2021.07.21.21260926. Previous page ‹‹ … Page 28 Page 29 Page 30 Page 31 Current page 32 Page 33 Page 34 Page 35 Page 36 … Next page ››